An Exploratory Study of Mometasone Furoate [mometasone] Nasal Spray in Patients With Moderate-Severe Persistent Allergic Rhinitis and Intermittent Asthma: Effects on the Quality of Life Evaluated With the Rhinasthma Questionnaire

Trial Profile

An Exploratory Study of Mometasone Furoate [mometasone] Nasal Spray in Patients With Moderate-Severe Persistent Allergic Rhinitis and Intermittent Asthma: Effects on the Quality of Life Evaluated With the Rhinasthma Questionnaire

Completed
Phase of Trial: Phase III

Latest Information Update: 18 Apr 2017

At a glance

  • Drugs Mometasone (Primary)
  • Indications Asthma; Perennial allergic rhinitis
  • Focus Therapeutic Use
  • Sponsors Schering-Plough
  • Most Recent Events

    • 26 Feb 2010 Results presented at the 66th Annual Meeting of the American Academy of Allergy, Asthma and Immunology.
    • 26 Feb 2010 Primary endpoint 'Rhinasthma Global Summary Scores' has been met according to results presented at the 66th Annual Meeting of the American Academy of Allergy, Asthma and Immunology.
    • 29 May 2009 Actual end date (Apr 2009) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top